» Articles » PMID: 766720

Postpsychotic Depression in Schizophrenia

Overview
Specialty Psychiatry
Date 1976 Feb 1
PMID 766720
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Several authors have described a severe depression in patients emerging from psychotic states. The clinical picture usually resembles that of a retarded depression with strong neurasthenic and schizoid components. It frequently emerges after a patient has been discharged from the hospital and may often go unnoticed. When manifest, the syndrome is usually stable phenomenologically, is often lengthy, and may be resistant to all modalities of treatment. Postpsychotic depression is a relatively neglected clinical area despite the risk of suicide and prolonged suffering. Therapeutic perseverence purportedly can improve the patient's long-term prognosis, and the phenomenon itself may be favorable prognostic sign. We present here a review and reformulation of this syndrome.

Citing Articles

Diagnosis and treatment depression in schizophrenia.

Mosolov S Consort Psychiatr. 2024; 1(2):29-42.

PMID: 39006901 PMC: 11240135. DOI: 10.17650/2712-7672-2020-1-2-29-42.


Identifying the mediating role of socioeconomic status on the relationship between schizophrenia and major depressive disorder: a Mendelian randomisation analysis.

Xu Q, Cai M, Ji Y, Ma J, Liu J, Zhao Q Schizophrenia (Heidelb). 2023; 9(1):53.

PMID: 37644044 PMC: 10465573. DOI: 10.1038/s41537-023-00389-2.


A case of postpsychotic depression improved by switching antipsychotic monotherapy.

Oguchi Y, Nakagawa A, Kocha H Neuropsychopharmacol Rep. 2022; 43(1):146-149.

PMID: 36482878 PMC: 10009410. DOI: 10.1002/npr2.12308.


Genetic Predisposition to Schizophrenia and Depressive Disorder Comorbidity.

Shnayder N, Novitsky M, Neznanov N, Limankin O, Asadullin A, Petrov A Genes (Basel). 2022; 13(3).

PMID: 35328011 PMC: 8950769. DOI: 10.3390/genes13030457.


Antidepressive Effect of Antipsychotics in the Treatment of Schizophrenia: Meta-Regression Analysis of Randomized Placebo-Controlled Trials.

Miura I, Nosaka T, Yabe H, Hagi K Int J Neuropsychopharmacol. 2020; 24(3):200-215.

PMID: 33151310 PMC: 7968624. DOI: 10.1093/ijnp/pyaa082.